Intended Purpose:

  • Healthy Inflammatory Response
  • Joint Health – Mobility & Flexibility
  • Allergy/Immune System – Immunoenhancement
  • Anti-Oxidant – DNA Protectant

May also Support:

  • Anti-Aging
  • Anti-Carcinogenic
  • Anti-Viral
  • Neuroprotection

Vincaria® is an alkaloid-deplete patented extract from the woodsy, outer bark of a neotropical liana (vine) indigenous to the Amazon River basin and surrounding rainforests. Commonly known as “Uńa de gato,” it is so called because the shape of its thorn resembles that of a cat’s claw. There are two species that are used: Uncaria tomentosa (UT) is the more well-known with a straight thorn while that of Uncaria guianensis (UG) has a thorn of spiral shape.

The initial Western research was conducted by a Swiss anthropologist who identified chemicals in UT which he assumed were the active constituents (alkaloids) that enhance the immune system. Problematically, the indigenous people harvest and use both UT and UG interchangeably yet UG has thirty times less of these alkaloids than UT. Additionally, Cat’s Claw has always been a natural medicine to relieve inflammation and as inflammation is a sign of an enhanced immune system, these alkaloids could not be responsible for its anti-inflammatory activity.

Thus, beginning in 1998, scientists at LSU Medical School and later Albany Medical College began studying the two cat’s claw species. It was discovered that UG acts as a powerful anti-inflammatory agent by regulating TNF alpha, the master “On-Off” switch in our bodies responsible for over thirty-five different types of inflammation – from arthritis to asthma. When alkaloid traces were extracted and removed from UG, a patented process which created Vincaria®, it was even more therapeutic.

Subsequently, a clinical trial was conducted in which a single once-a-day 100 milligram dose of Vincaria® was effective in ninety percent of patients, the majority in less than five days.  It was then used as an anti-inflammatory component, both to promote healthy skeletal, muscular and gastric health in obesity. In a separate trial, it was combined with a natural mineral supplement again successful for arthritis and later, with RNI 249, a maca extract, for osteoarthritis of the knee.

While its primary inclusion in this formula is to ameliorate conditions associated with inflammation, indeed using a dose higher than in clinical trials, there is good evidence that Cat’s Claw is an effective neuroprotectant, most likely through a DNA oxidative “shield” and act as a powerful anti-oxidant (and thus play a role in slowing down the aging process).

(1) Mehta K, Gala J, Bhasale S et al: Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351].BMC Complement Altern Med. 2007 Oct 31;7:34. http://www.ncbi.nlm.nih.gov/pubmed/17974032

(2) Piscoya J, Rodriguez Z, Bustamante SA et al: Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflamm Res. 2001 Sep;50(9):442-8. http://www.ncbi.nlm.nih.gov/pubmed/11603848

(3) Miller MJ, Mehta K, Kunte S et al: Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [ISRCTN38432711]. J Inflamm (Lond). 2005 Oct 21;2:11. http://www.ncbi.nlm.nih.gov/pubmed/16242032

(4) Sandoval M, Okuhama NN, Zhang XJ et al: Anti-inflammatory and antioxidant activities of cat’s claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine. 2002 May;9(4):325-37. http://www.ncbi.nlm.nih.gov/pubmed/12120814

(5) J. F. Gmelin, Carvalho MV, Penido C et al: Investigations on the anti-inflammatory and anti-allergic activities of the leaves of Uncaria guianensis (Aublet). Inflammopharmacology. 2006 Mar;14(1-2):48-56. http://www.ncbi.nlm.nih.gov/pubmed/16835713

(6) Miller MJ, Ahmed S, Bobrowski P et al: The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta. BMC Complement Altern Med. 2006 Apr 7;6:13. http://www.ncbi.nlm.nih.gov/pubmed/16603065

(7) Correia AF, Segovia JF, Gonçalves MC et al: Amazonian plant crude extract screening for activity against multidrug-resistant bacteria. Eur Rev Med Pharmacol Sci. 2008 Nov-Dec;12(6):369-80. http://www.ncbi.nlm.nih.gov/pubmed/19146199

(8) Urdanibia I, Michelangeli F, Ruiz MC et al: Anti-inflammatory and antitumoural effects of Uncaria guianensis bark. J Ethnopharmacol. 2013 Dec 12;150(3):1154-62. http://www.ncbi.nlm.nih.gov/pubmed/24212077

(9) Dietrich F, Kaiser S, Rockenbach L et al: Quinovic acid glycosides purified fraction from Uncaria tomentosa induces cell death by apoptosis in the T24 human bladder cancer cell line. Food Chem Toxicol. 2014 May;67:222-9. http://www.ncbi.nlm.nih.gov/pubmed/24607820

(10) Caon T, Kaiser S, Feltrin C et al: Antimutagenic and antiherpetic activities of different preparations from Uncaria tomentosa (cat’s claw). Food Chem Toxicol. 2014 Apr;66:30-5. http://www.ncbi.nlm.nih.gov/pubmed/24447975

(11) Lima-Junior RS, Mello Cda S, Siani AC et al: Uncaria tomentosa alkaloidal fraction reduces paracellular permeability, IL-8 and NS1 production on human microvascular endothelial cells infected with dengue virus. Nat Prod Commun. 2013 Nov;8(11):1547-50. http://www.ncbi.nlm.nih.gov/pubmed/24427938

(12) Kaiser S, Dietrich F, de Resende PE et al: Cat’s claw oxindole alkaloid isomerization induced by cell incubation and cytotoxic activity against T24 and RT4 human bladder cancer cell lines. Planta Med. 2013 Oct;79(15):1413-20. http://www.ncbi.nlm.nih.gov/pubmed/23975868

(13) Shi Z, Lu Z, Zhao Y et al: Neuroprotective effects of aqueous extracts of Uncaria tomentosa: Insights from 6-OHDA induced cell damage and transgenic Caenorhabditis elegans model. Neurochem Int. 2013 Jun;62(7):940-7. http://www.ncbi.nlm.nih.gov/pubmed/23500604

(14) Dreifuss AA, Bastos-Pereira AL, Fabossi IA et al: Uncaria tomentosa exerts extensive anti-neoplastic effects against the Walker-256 tumour by modulating oxidative stress and not by alkaloid activity. PLoS One. 2013;8(2):e54618. http://www.ncbi.nlm.nih.gov/pubmed/23408945

(15) Mur E, Hartig F, Eibl G, Schirmer M: Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. J Rheumatol. 2002 Apr;29(4):678-81. http://www.ncbi.nlm.nih.gov/pubmed/11950006

(16) Rojas-Duran R, González-Aspajo G, Ruiz-Martel C et al: Anti-inflammatory activity of Mitraphylline isolated from Uncaria tomentosa bark. J Ethnopharmacol. 2012 Oct 11;143(3):801-4. http://www.ncbi.nlm.nih.gov/pubmed/22846434

(17) Santos Araújo Mdo C, Farias IL, Gutierres J et al: Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial. Evid Based Complement Alternat Med. 2012; 2012:676984. http://www.ncbi.nlm.nih.gov/pubmed/22811748

(18) Bors M, Michałowicz J, Pilarski R et al: Studies of biological properties of Uncaria tomentosa extracts on human blood mononuclear cells. J Ethnopharmacol. 2012 Aug 1;142(3):669-78. http://www.ncbi.nlm.nih.gov/pubmed/22683905

(19) Akhtar N, Miller MJ, Haqqi TM et al: Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes. BMC Complement Altern Med. 2011 Aug 19;11:66. http://www.ncbi.nlm.nih.gov/pubmed/21854562

(20) Guthrie OW, Gearhart CA, Fulton S et al: Carboxy alkyl esters of Uncaria tomentosa augment recovery of sensorineural functions following noise injury. Brain Res. 2011 Aug 17;1407:97-106. http://www.ncbi.nlm.nih.gov/pubmed/21762882

(21) Domingues A, Sartori A, Golim MA et al: Prevention of experimental diabetes by Uncaria tomentosa extract: Th2 polarization, regulatory T cell preservation or both? J Ethnopharmacol. 2011 Sep 1;137(1):635-42. http://www.ncbi.nlm.nih.gov/pubmed/21718770

(22) Bors M, Bukowska B, Pilarski R et al: Protective activity of the Uncaria tomentosa extracts on human erythrocytes in oxidative stress induced by 2,4-dichlorophenol (2,4-DCP) and catechol. Food Chem Toxicol. 2011 Sep;49(9):2202-11. http://www.ncbi.nlm.nih.gov/pubmed/21712061

(23) Domingues A, Sartori A, Valente LM et al: Uncaria tomentosa aqueous-ethanol extract triggers an immunomodulation toward a Th2 cytokine profile. Phytother Res. 2011 Aug;25(8):1229-35. http://www.ncbi.nlm.nih.gov/pubmed/21656603

(24) Miller AK, Benson JM, Muanza DN et al: Anti-inflammatory effects of natural product formulations on murine dendritic cells. J Diet Suppl. 2011 Mar;8(1):19-33. http://www.ncbi.nlm.nih.gov/pubmed/21399725

(25) Anter J, Romero-Jiménez M, Fernández-Bedmar Z et al: Antigenotoxicity, cytotoxicity, and apoptosis induction by apigenin, bisabolol, and protocatechuic acid. J Med Food. 2011 Mar;14(3):276-83. http://www.ncbi.nlm.nih.gov/pubmed/21182433

(26) Gurrola-Díaz CM, García-López PM, Gulewicz K et al: Inhibitory mechanisms of two Uncaria tomentosa extracts affecting the Wnt-signaling pathway. Phytomedicine. 2011 Jun 15;18(8-9):683-90. http://www.ncbi.nlm.nih.gov/pubmed/21156346

(27) Nogueira Neto J, Coelho TM, Aguiar GC et al: Experimental endometriosis reduction in rats treated with Uncaria tomentosa (cat’s claw) extract. Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):205-8. http://www.ncbi.nlm.nih.gov/pubmed/21030132

(28) Herrera DR, Tay LY, Rezende EC et al: In vitro antimicrobial activity of phytotherapic Uncaria tomentosa against endodontic pathogens. J Oral Sci. 2010 Sep;52(3):473-6. http://www.ncbi.nlm.nih.gov/pubmed/20881342

(29) Pilarski R, Filip B, Wietrzyk J et al: Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition. Phytomedicine. 2010 Dec 1;17(14):1133-9. http://www.ncbi.nlm.nih.gov/pubmed/20576410

(30) Dreifuss AA, Bastos-Pereira AL, Avila TV et al: Antitumoral and antioxidant effects of a hydroalcoholic extract of cat’s claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model. J Ethnopharmacol. 2010 Jul 6;130(1):127-33. http://www.ncbi.nlm.nih.gov/pubmed/20435132

(31) Rinner B, Li ZX, Haas Het al: Antiproliferative and pro-apoptotic effects of Uncaria tomentosa in human medullary thyroid carcinoma cells. Anticancer Res. 2009 Nov;29(11):4519-28. http://www.ncbi.nlm.nih.gov/pubmed/20032400

(32) Allen-Hall L, Arnason JT, Cano P et al: Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol. 2010 Feb 17;127(3):685-93. http://www.ncbi.nlm.nih.gov/pubmed/19995599

(33) García Giménez D, García Prado E, Sáenz Rodríguez T et al: Cytotoxic effect of the pentacyclic oxindole alkaloid mitraphylline isolated from Uncaria tomentosa bark on human Ewing’s sarcoma and breast cancer cell lines. Planta Med. 2010 Feb;76(2):133-6. http://www.ncbi.nlm.nih.gov/pubmed/19724995

(34) Zeng K, Thompson KE, Yates CR et al: Synthesis and biological evaluation of quinic acid derivatives as anti- inflammatory agents. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5458-60. http://www.ncbi.nlm.nih.gov/pubmed/19674895

(35) Amaral S, Mira L, Nogueira JM et al: Plant extracts with anti-inflammatory properties–a new approach for characterization of their bioactive compounds and establishment of structure-antioxidant activity relationships. Bioorg Med Chem. 2009 Mar 1;17(5):1876-83. http://www.ncbi.nlm.nih.gov/pubmed/19201196

(36) Paniagua-Pérez R, Madrigal-Bujaidar E, Molina-Jasso D et al: Antigenotoxic, antioxidant and lymphocyte induction effects produced by pteropodine. Basic Clin Pharmacol Toxicol. 2009 Mar;104(3):222-7. http://www.ncbi.nlm.nih.gov/pubmed/19175366

(37) Reis SR, Valente LM, Sampaio AL et al: Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2. Int Immunopharmacol. 2008 Mar;8(3):468-76. http://www.ncbi.nlm.nih.gov/pubmed/18279801

(38) Pilarski R, Poczekaj-Kostrzewska M, Ciesiołka D et al: Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells. Pharmacol Rep. 2007 Sep-Oct;59(5):565-72. http://www.ncbi.nlm.nih.gov/pubmed/18048957

(39) Cheng AC, Jian CB, Huang YT et al: Induction of apoptosis by Uncaria tomentosa through reactive oxygen species production, cytochrome c release, and caspases activation in human leukemia cells. Food Chem Toxicol. 2007 Nov;45(11):2206-18. http://www.ncbi.nlm.nih.gov/pubmed/17619071

(40) Ccahuana-Vasquez RA, Santos SS, Koga-Ito CY et al: Antimicrobial activity of Uncaria tomentosa against oral human pathogens. Braz Oral Res. 2007 Jan-Mar;21(1):46-50. http://www.ncbi.nlm.nih.gov/pubmed/17426895

(41) García Prado E, García Gimenez MD, De la Puerta Vázquez R et al: Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Phytomedicine. 2007 Apr;14(4):280-4. http://www.ncbi.nlm.nih.gov/pubmed/17296291

(42) Frackowiak T, Baczek T, Roman K et al: Binding of an oxindole alkaloid from Uncaria tomentosa to amyloid protein (Abeta1-40). Z Naturforsch C. 2006 Nov-Dec;61(11-12):821-6. http://www.ncbi.nlm.nih.gov/pubmed/17294693

(43) Hardin SR: Cat’s claw: an Amazonian vine decreases inflammation in osteoarthritis. Complement Ther Clin Pract. 2007 Feb;13(1):25-8. http://www.ncbi.nlm.nih.gov/pubmed/17210508

(44) Gonzales GF, Valerio LG Jr: Medicinal plants from Peru: a review of plants as potential agents against cancer. Anticancer Agents Med Chem. 2006 Sep;6(5):429-44. Review. http://www.ncbi.nlm.nih.gov/pubmed/17017852

(45) Allen-Hall L, Cano P, Arnason JT et al: Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1beta and TNF-alpha. J Ethnopharmacol. 2007 Jan 19;109(2):312-7. http://www.ncbi.nlm.nih.gov/pubmed/16959454

(46) Spelman K, Burns J, Nichols D et al: Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006 Jun;11(2):128-50. Review. http://www.ncbi.nlm.nih.gov/pubmed/16813462

(47) De Martino L, Martinot JL, Franceschelli S et al: Proapoptotic effect of Uncaria tomentosa extracts. J Ethnopharmacol. 2006 Aug 11;107(1):91-4. http://www.ncbi.nlm.nih.gov/pubmed/16569487

(48) Mammone T, Akesson C, Gan D et al: A water soluble extract from Uncaria tomentosa (Cat’s Claw) is a potent enhancer of DNA repair in primary organ cultures of human skin. Phytother Res. 2006 Mar;20(3):178-83. http://www.ncbi.nlm.nih.gov/pubmed/16521105

(49) Bacher N, Tiefenthaler M, Sturm S et al: Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells. Br J Haematol. 2006 Mar;132(5):615-22. http://www.ncbi.nlm.nih.gov/pubmed/16445836

(50) Pilarski R, Zieliński H, Ciesiołka D et al: Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC. J Ethnopharmacol. 2006 Mar 8;104(1-2):18-23. http://www.ncbi.nlm.nih.gov/pubmed/16202551

(51) Styczynski J, Wysocki M; Alternative medicine remedies might stimulate viability of leukemic cells. Pediatr Blood Cancer. 2006 Jan;46(1):94-8. http://www.ncbi.nlm.nih.gov/pubmed/16047362

(52) García R, Cayunao C, Bocic R et al: Antimicrobial activity of isopteropodine. Z Naturforsch C. 2005 May-Jun;60(5-6):385-8. http://www.ncbi.nlm.nih.gov/pubmed/16042336

(53) Romero-Jiménez M, Campos-Sánchez J, Analla M et al: Genotoxicity and anti-genotoxicity of some traditional medicinal herbs. Mutat Res. 2005 Aug 1;585(1-2):147-55. http://www.ncbi.nlm.nih.gov/pubmed/16005256.

(54) Setty AR, Sigal LH: Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum. 2005 Jun;34(6):773-84. Review. http://www.ncbi.nlm.nih.gov/pubmed/15942912

(55) Eberlin S, dos Santos LM, Queiroz ML: Uncaria tomentosa extract increases the number of myeloid progenitor cells in the bone marrow of mice infected with Listeria monocytogenes. Int Immunopharmacol. 2005 Jul;5(7-8):1235-46. http://www.ncbi.nlm.nih.gov/pubmed/15914328

(56) Jürgensen S, Dalbó S, Angers P et al: Involvement of 5-HT2 receptors in the antinociceptive effect of Uncaria tomentosa. Pharmacol Biochem Behav. 2005 Jul;81(3):466-77. http://www.ncbi.nlm.nih.gov/pubmed/15907989

(57) Gonçalves C, Dinis T, Batista MT: Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity. Phytochemistry. 2005 Jan;66(1):89-98. http://www.ncbi.nlm.nih.gov/pubmed/15649515

(58) Heitzman ME, Neto CC, Winiarz E et al: Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry. 2005 Jan;66(1):5-29. Review. http://www.ncbi.nlm.nih.gov/pubmed/15649507

(59) Sheng Y, Akesson C, Holmgren K et al: An active ingredient of Cat’s Claw water extracts identification and efficacy of quinic acid. J Ethnopharmacol. 2005 Jan 15;96(3):577-84. http://www.ncbi.nlm.nih.gov/pubmed/15619581

(60) Cisneros FJ, Jayo M, Niedziela L: An Uncaria tomentosa (cat’s claw) extract protects mice against ozone-induced lung inflammation. J Ethnopharmacol. 2005 Jan 15;96(3):355-64. http://www.ncbi.nlm.nih.gov/pubmed/15619552

(61) Akesson C, Lindgren H, Pero RW et al: Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100. Int Immunopharmacol. 2005 Jan;5(1):219-29. http://www.ncbi.nlm.nih.gov/pubmed/15589483

(62) Deharo E, Baelmans R, Gimenez A et al: In vitro immunomodulatory activity of plants used by the Tacana ethnic group in Bolivia. Phytomedicine. 2004 Sep;11(6):516-22. http://www.ncbi.nlm.nih.gov/pubmed/15500263

(63) Winkler C, Wirleitner B, Schroecksnadel K et al: In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells. Planta Med. 2004 Mar;70(3):205-10. http://www.ncbi.nlm.nih.gov/pubmed/15114496

(64) Akesson C, Lindgren H, Pero RW et al: An extract of Uncaria tomentosa inhibiting cell division and NF-kappa B activity without inducing cell death. Int Immunopharmacol. 2003 Dec;3(13-14):1889-900. http://www.ncbi.nlm.nih.gov/pubmed/14636838

(65) Akesson Ch, Pero RW, Ivars F: C-Med 100, a hot water extract of Uncaria tomentosa, prolongs lymphocyte survival in vivo. Phytomedicine. 2003 Jan;10(1):23-33. http://www.ncbi.nlm.nih.gov/pubmed/12622460

(66) Kang TH, Matsumoto K, Tohda M et al: Pteropodine and isopteropodine positively modulate the function of rat muscarinic M(1) and 5-HT(2) receptors expressed in Xenopus oocyte. Eur J Pharmacol. 2002 May 24;444(1-2):39-45. http://www.ncbi.nlm.nih.gov/pubmed/12191580

(67) Sandoval M, Okuhama NN, Zhang XJ et al: Anti-inflammatory and antioxidant activities of cat’s claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine. 2002 May;9(4):325-37. http://www.ncbi.nlm.nih.gov/pubmed/12120814

(68) Aguilar JL, Rojas P, Marcelo A et al: Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). J Ethnopharmacol. 2002 Jul;81(2):271-6. http://www.ncbi.nlm.nih.gov/pubmed/12065162

(69) Mur E, Hartig F, Eibl G et al: Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. J Rheumatol. 2002 Apr;29(4):678-81. http://www.ncbi.nlm.nih.gov/pubmed/11950006

(70) Williams JE: Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev. 2001 Dec;6(6):567-79. Review. http://www.ncbi.nlm.nih.gov/pubmed/11804547

(71) Riva L, Coradini D, Di Fronzo G et al: The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Res. 2001 Jul-Aug;21(4A):2457-61. http://www.ncbi.nlm.nih.gov/pubmed/11724307

(72) Piscoya J, Rodriguez Z, Bustamante SA et al: Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflamm Res. 2001 Sep;50(9):442-8. http://www.ncbi.nlm.nih.gov/pubmed/11603848

(73) Sheng Y, Li L, Holmgren K et al: DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. Phytomedicine. 2001 Jul;8(4):275-82. http://www.ncbi.nlm.nih.gov/pubmed/11515717

(74) Lamm S, Sheng Y, Pero RW: Persistent response to pneumococcal vaccine in individuals supplemented with a novel water soluble extract of Uncaria tomentosa, C-Med-100. Phytomedicine. 2001 Jul;8(4):267-74. http://www.ncbi.nlm.nih.gov/pubmed/11515716

(75) Muhammad I, Dunbar DC, Khan RA et al: Investigation of Uña De Gato I. 7-Deoxyloganic acid and 15N NMR spectroscopic studies on pentacyclic oxindole alkaloids from Uncaria tomentosa. Phytochemistry. 2001 Jul;57(5):781-5. http://www.ncbi.nlm.nih.gov/pubmed/11397448

(76) Muhammad I, Khan IA, Fischer NH et al: Two stereoisomeric pentacyclic oxindole alkaloids from Uncaria tomentosa: uncarine C and uncarine E. Acta Crystallogr C. 2001 Apr;57(Pt 4):480-2. http://www.ncbi.nlm.nih.gov/pubmed/11313600

(77) Mohamed AF, Matsumoto K, Tabata K et al: Effects of Uncaria tomentosa total alkaloid and its components on experimental amnesia in mice: elucidation using the passive avoidance test. J Pharm Pharmacol. 2000 Dec;52(12):1553-61. http://www.ncbi.nlm.nih.gov/pubmed/11197086

(78) Budzinski JW, Foster BC, Vandenhoek S et al: An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine. 2000 Jul;7(4):273-82. http://www.ncbi.nlm.nih.gov/pubmed/10969720

(79) Sandoval M, Charbonnet RM, Okuhama NN et al: Cat’s claw inhibits TNFalpha production and scavenges free radicals: role in cytoprotection. Free Radic Biol Med. 2000 Jul 1;29(1):71-8. http://www.ncbi.nlm.nih.gov/pubmed/10962207

(80) Sheng Y, Pero RW, Wagner H: Treatment of chemotherapy-induced leukopenia in a rat model with aqueous extract from Uncaria tomentosa. Phytomedicine. 2000 Apr;7(2):137-43. http://www.ncbi.nlm.nih.gov/pubmed/10839217

(81) Sheng Y, Bryngelsson C, Pero RW: Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa. J Ethnopharmacol. 2000 Feb;69(2):115-26. http://www.ncbi.nlm.nih.gov/pubmed/10687868

(82) Reinhard KH: Uncaria tomentosa (Willd.) D.C.: cat’s claw, uña de gato, or savéntaro. J Altern Complement Med. 1999 Apr;5(2):143-51. Review. http://www.ncbi.nlm.nih.gov/pubmed/10328636

(83) Lemaire I, Assinewe V, Cano P et al: Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (uña de gato) J Ethnopharmacol. 1999 http://www.ncbi.nlm.nih.gov/pubmed/10197746

(84) Keplinger K, Laus G, Wurm M et al: Uncaria tomentosa (Willd.) DC.–ethnomedicinal use and new pharmacological, toxicological and botanical results. J Ethnopharmacol. 1999 Jan;64(1):23-34. Review. http://www.ncbi.nlm.nih.gov/pubmed/10075119

(85) Wurm M, Kacani L, Laus G et al: Pentacyclic oxindole alkaloids from Uncaria tomentosa induce human endothelial cells to release a lymphocyte-proliferation-regulating factor. Planta Med. 1998 Dec;64(8):701-4. http://www.ncbi.nlm.nih.gov/pubmed/9933988

(86) Sandoval-Chacón M, Thompson JH et al: Antiinflammatory actions of cat’s claw: the role of NF-kappaB. Aliment Pharmacol Ther. 1998 Dec;12(12):1279-89. http://www.ncbi.nlm.nih.gov/pubmed/9882039

(87) Sheng Y, Pero RW, Amiri A et al: Induction of apoptosis and inhibition of proliferation in human tumor cells treated with extracts of Uncaria tomentosa. Anticancer Res. 1998 Sep-Oct;18(5A):3363-8. http://www.ncbi.nlm.nih.gov/pubmed/9858909

(88) Salazar EL, Jayme V: Depletion of specific binding sites for estrogen receptor by Uncaria tomentosa. Proc West Pharmacol Soc. 1998;41:123-4. http://www.ncbi.nlm.nih.gov/pubmed/9836266

(89) Wirth C, Wagner H: Pharmacologically active procyanidines from the bark of Uncaria tomentosa. Phytomedicine. 1997 Sep;4(3):265-6. http://www.ncbi.nlm.nih.gov/pubmed/23195487

(90) Santa Maria A, Lopez A, Diaz MM et al: Evaluation of the toxicity of Uncaria tomentosa by bioassays in vitro. J Ethnopharmacol. 1997 Aug;57(3):183-7. http://www.ncbi.nlm.nih.gov/pubmed/9292411

(91) Rizzi R, Re F, Bianchi A et al: Mutagenic and antimutagenic activities of Uncaria tomentosa and its extracts. J Ethnopharmacol. 1993 Jan;38(1):63-77. http://www.ncbi.nlm.nih.gov/pubmed/8479203

(92) Aquino R, De Feo V, De Simone F et al: Plant metabolites. New compounds and anti-inflammatory activity of Uncaria tomentosa. J Nat Prod. 1991 Mar-Apr;54(2):453-9. http://www.ncbi.nlm.nih.gov/pubmed/1919590

(93) Aquino R, De Simone F, Pizza C et al: Plant metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platypoda. J Nat Prod. 1989 Jul-Aug;52(4):679-85. http://www.ncbi.nlm.nih.gov/pubmed/2553871

(94) Senatore A, Cataldo A, Iaccarino FP et al: Phytochemical and biological study of Uncaria tomentosa. Boll Soc Ital Biol Sper. 1989 Jun;65(6):517-20. Italian. http://www.ncbi.nlm.nih.gov/pubmed/2611012

(95) Wagner H, Kreutzkamp B, Jurcic K: The alkaloids of Uncaria tomentosa and their phagocytosis-stimulating action. Planta Med. 1985 Oct;(5):419-23. German. http://www.ncbi.nlm.nih.gov/pubmed/4080851

(96) Pero RW: Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester. USPTO 8,372,449: Feb 12, 2013. http://1.usa.gov/1zVB81B

(97) Pero RW: Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester. USPTO 8,372,448: Feb 12, 2013. http://1.usa.gov/1FhM9MR

(98) Pero RW: Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester. USPTO 7,955,626: Jun 7, 2011. http://1.usa.gov/1H0AiO7

(99) Pero RW: Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals. USPTO 7,947,312: May 24, 2011. http://1.usa.gov/1RyQsa7

(100) Castillo GM et al: Composition and methods for treating Alzheimer’s disease and other amyloidosis. USPTO 7,754,250: Jul 13, 2010. http://1.usa.gov/1ATDh9d

(101) Castillo G et al: Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants. USPTO 7,314,642: Jan 1, 2008. http://1.usa.gov/1ATDfOC

(102) Pero RW: Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals. USPTO 6,964,784: Nov 15, 2005. http://1.usa.gov/1HbrwzA

(103) Bobrowski PJ: Methods and preparations of extracts of Uncaria species with reduced alkaloid content. USPTO 6,797,286: Sep 28, 2004. http://1.usa.gov/1KE5JRv

(104) Pero RW: Method of preparation and composition of a water soluble extract of the plant species uncaria. USPTO 6,039,949: Mar 21, 2000. http://1.usa.gov/1PE7P5A

(105) Keplinger K et al: Oxindole alkaloids having properties stimulating the immunologic system & preparation containing the same. USPTO 5,302,611: Apr 12, 1994. http://1.usa.gov/1QEYU6h

(106) Keplinger K et al: Oxindole alkaloids having properties stimulating the immunologic system and preparation containing the same. USPTO 4,940,725; Jul 10, 1990. http://1.usa.gov/1cMNpLM

(107) Keplinger K et al: Oxindole alkaloids having properties stimulating the immunologic system. USPTO 4,844,901: Jul 4, 1989. http://1.usa.gov/1PfTZeG